ANDAORALTABLET, ORALLY DISINTEGRATING
Approved
Jun 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
10
Clinical Trials (5)
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
Started Oct 2008
184 enrolled
Sleep Initiation and Maintenance DisordersMental DisordersDyssomnias+2 more
A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)
Started Jan 2008
259 enrolled
Sleep Initiation and Maintenance Disorder; ElderlyMental DisorderDyssomnias+2 more
Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709)
Started Nov 2007
538 enrolled
InsomniaSleep Initiation and Maintenance DisordersMental Disorders+2 more
A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707)
Started Jun 2007
419 enrolled
Insomnia
Study of the Safety and Effectiveness of Esmirtazapine in Participants With Chronic Primary Insomnia (P05706)
Started Dec 2006
526 enrolled
Insomnia